Tff Pharmaceuticals Inc
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voricona… Read more
Tff Pharmaceuticals Inc (TFFP) - Total Assets
Latest total assets as of September 2024: $7.08 Million USD
Based on the latest financial reports, Tff Pharmaceuticals Inc (TFFP) holds total assets worth $7.08 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tff Pharmaceuticals Inc - Total Assets Trend (2017–2023)
This chart illustrates how Tff Pharmaceuticals Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tff Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Tff Pharmaceuticals Inc's total assets of $7.08 Million consist of 63.1% current assets and 36.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 45.6% |
| Accounts Receivable | $433.85K | 3.6% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2023)
This chart illustrates how Tff Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tff Pharmaceuticals Inc's current assets represent 63.1% of total assets in 2023, an increase from 0.0% in 2017.
- Cash Position: Cash and equivalents constituted 45.6% of total assets in 2023, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 3.6% of total assets.
Tff Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Tff Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Tff Pharmaceuticals Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Tff Pharmaceuticals Inc generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Tff Pharmaceuticals Inc is currently not profitable relative to its asset base.
Tff Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 9.54 | 71.08 |
| Quick Ratio | 0.89 | 9.54 | 71.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-432.35K | $ 9.75 Million | $ 28.78 Million |
Tff Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Tff Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.09 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -50.1% |
| Total Assets | $12.03 Million |
| Market Capitalization | $181.70K USD |
Valuation Analysis
Below Book Valuation: The market values Tff Pharmaceuticals Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tff Pharmaceuticals Inc's assets decreased by 50.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tff Pharmaceuticals Inc (2017–2023)
The table below shows the annual total assets of Tff Pharmaceuticals Inc from 2017 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $12.03 Million | -50.14% |
| 2022-12-31 | $24.12 Million | -40.73% |
| 2021-12-31 | $40.70 Million | +5.27% |
| 2020-12-31 | $38.66 Million | +32.46% |
| 2019-12-31 | $29.19 Million | +180.61% |
| 2018-12-31 | $10.40 Million | -- |
| 2017-12-31 | $0.00 | -- |